|
| Exchange Received Time 24/10/2019 09:34:41 Exchange Disseminated Time 24/10/2019 09:34:49 Time Taken 00:00:08 | With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Approval for Desonide Ointment, 0.05%.
Please find enclosed herewith our press release.
We request you to kindly take the same on record.
|
|
|